Table 2.

Patient characteristics, early change during NAC^a, overall response and surgery type for non-mass type lesions

^a NAC, neoadjuvant chemotherapy; ^b FEC, fluorouracil+epirubicin+cyclophosphamide;

Patient	Age	TNM stage	ER/PgR	HER2	After 1 course of FECb		Response after full course of NAC	Surgery
					∆ADCc(%)	∆diameterd(%)
8Re	65	IIIB	+/+	-	11	-2	NR	Mf
9	69	IIIB	+/+	-	10	0	NR	M
10	49	IIB	+/+	-	-11	18	R	M
11	50	IIIA	+/+	-	22	36	R	M

^c∆ADC, change in ADC (apparent diffusion coefficient) value after first cycle of FEC;

^d∆diameter, change in largest diameter captured one-dimensionally after first course of FEC; ^e8R, patient with bilateral breast cancer, right breast; ^fM, mastectomy